Study finds Alzheimer's cases will double in US by 2060 | Study IDs factors associated with CVD risk in type 2 diabetes | Women with Parkinson's disease less likely to have caregiver
December 11, 2017
CONNECT WITH SNMMI LinkedInFacebookTwitterYoutube
SNMMI SmartBrief
News for nuclear medicine and molecular imaging professionals
SIGN UP ⋅   FORWARD
Top Story
Study finds Alzheimer's cases will double in US by 2060
A study estimated the number of US Alzheimer's disease cases will double by 2060, and author Ron Brookmeyer said the findings highlight the need for ways to better identify people who will develop the disease and for new interventions to slow or stop disease progression. The research, published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, found that about 5.7 million people will have mild cognitive impairment and 9.3 million will have Alzheimer's disease by 2060.
HealthDay News (12/7) 
LinkedIn Twitter Facebook Google+ Email
Clinical News & Research
Study IDs factors associated with CVD risk in type 2 diabetes
Researchers found that patients with newly diagnosed type 2 diabetes who achieve early and maintained A1C control between 6.5% and 7% were at a reduced likelihood of experiencing a cardiovascular event than those who maintain an aggressive or poor glycemic control. The findings in Current Medical Research and Opinion, based on data from 11,426 patients, also revealed that aggressive glucose control increases macrovascular risk among those with a longer diabetes duration and those with poor glycemic control at the time of the intensive therapy initiation.
Healio (free registration)/Endocrine Today (12/5) 
LinkedIn Twitter Facebook Google+ Email
Women with Parkinson's disease less likely to have caregiver
Data showed 88.4% of men with Parkinson's disease had a caregiver, compared with 79.4% of women, and caregiver strain was greater for those caring for men, according to a study in Neurology. Women were less likely than men to have a caregiver accompany them for a baseline medical visit and went to using a paid caregiver at a faster rate than men.
Physician's Briefing/HealthDay News (12/5) 
LinkedIn Twitter Facebook Google+ Email
AI improves polyp detection during colonoscopy, studies say
The use of artificial intelligence can increase the accuracy and sensitivity of adenoma detection during colonoscopy, even for small lesions, Dr. William Karnes of the University of California at Irvine told the World Congress of Gastroenterology at ACG 2017. Dr. Yuichi Mori of Showa University in Shinagawa-ku, Japan, reported at United European Gastroenterology Week 2017 that the EndoBRAIN computer-aided system yielded an automatic diagnosis of a lesion during colonoscopy and had a high polyp detection rate.
Medscape (free registration) (12/4) 
LinkedIn Twitter Facebook Google+ Email
Industry Report
Genentech wins full approval of treatment-resistant brain cancer drug
The FDA granted full approval to Roche Holding unit Genentech's Avastin, or bevacizumab, which is intended to treat glioblastoma in adult patients whose disease progressed after prior treatment. The company previously received provisional approval under the agency's accelerated approval provision.
Seeking Alpha (free registration) (12/6) 
LinkedIn Twitter Facebook Google+ Email
Novartis' AML drug turned down by NICE
The National Institute for Health and Care Excellence recommended against National Health Service and Cancer Drugs Fund use of Novartis' Rydapt, or midostaurin, as a treatment for patients with FLT3-mutated acute myeloid leukemia. The regulator did not consider the drug cost-effective and was uncertain of Rydapt's effectiveness in people older than age 60 because a clinical trial did not include that age group.
PharmaTimes (U.K.) (12/6) 
LinkedIn Twitter Facebook Google+ Email
News from the Field
Researchers to develop advance care planning program for dementia patients
Researchers and nursing homes are using an NIH grant to develop an advance care planning program for patients with Alzheimer's disease and other dementias that can be integrated into the homes' regular workflows. The project aims to create decision-making supports and have nursing home staff work with residents and their families on care goals and values.
McKnight's Long-Term Care News online (12/6) 
LinkedIn Twitter Facebook Google+ Email
Health Policy
Health insurance tax on the table in Congress
House Republicans are looking at delaying the Affordable Care Act's tax on health insurance for only some markets next year, leaving the tax in place for small businesses and potentially private Medicaid plans. The tax would be suspended for all markets in 2019 if the measure is included in a year-end bill that also might delay the medical device tax, relax health savings account restrictions and put the Cadillac tax on hold.
Politico (12/7) 
LinkedIn Twitter Facebook Google+ Email
Advancing Health Care
4 health organizations to pilot OurNotes initiative
A pilot program for OurNotes, an initiative targeting patient-provider collaboration in writing clinical notes and care plans within a shared EHR, will begin in the spring at Beth Israel Deaconess Medical Center, the University of Colorado, the University of Washington and Dartmouth-Hitchcock Medical Center. Beth Israel, which uses its own EHR system, will aid in organizing and standardizing efforts with the other sites, which use Epic systems, said Dr. Matthew Germak of Beth Israel.
Health Data Management (free registration) (12/5) 
LinkedIn Twitter Facebook Google+ Email
From SNMMI
One week remains to save on your AACR-SNMMI Joint Conference registration
Register by Monday, Dec. 18, and save up to $400 off your AACR-SNMMI Joint Conference on State-of-the-Art Molecular Imaging in Cancer Biology and Therapy registration. You'll connect with the profession's foremost experts on topics including emerging advances in imaging technologies; super-resolution imaging of cancer biology and metastasis; novel ligands and target identification; optics in the oncology surgical suite; and more! Advance registration ends Dec. 18. Register today.
LinkedIn Twitter Facebook Google+ Email
Today is the application deadline for the Slosky and Henkin fellowships
Early-career professionals in nuclear medicine and molecular imaging are encouraged to apply for the 2018 Ursula Mary-Kocemba Slosky, PhD, Professional Relations Fellowship or the 2018 Robert E. Henkin, MD, Government Relations Fellowship. The Slosky fellowship provides direct, personal exposure to professional/public relations activities of the SNMMI as they relate to other medical societies and professional organizations. The Henkin fellowship provides firsthand experience in health policy development. Submit today!
LinkedIn Twitter Facebook Google+ Email
Learn more about SNMMI:
SNMMI | News & Publications | Meetings | Education
Membership | Support Education/Research in Your Field
  
  
Honor is self-esteem made visible in action.
Ayn Rand,
writer
LinkedIn Twitter Facebook Google+ Email
  
  
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items above are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.
Sign Up
SmartBrief offers 200+ newsletters
Advertise
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Editor  -  Tara Rosenzweig
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information